Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection

Dengue is endemic throughout tropical and subtropical regions of the world. Currently, there is no clinically approved therapeutic drug available for this acute viral infection. Although the first dengue vaccine Dengvaxia has been approved for use in certain countries, it is limited to those without...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Wei-Lian, Lee, Yean Kee, Ho, Yen Fong, Yusof, Rohana, Abdul Rahman, Noorsaadah, Karsani, Saiful Anuar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2018
Materias:
Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796277/
https://www.ncbi.nlm.nih.gov/pubmed/29404200
http://dx.doi.org/10.7717/peerj.3939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796277/
https://www.ncbi.nlm.nih.gov/pubmed/29404200
http://dx.doi.org/10.7717/peerj.3939

Ejemplares similares